Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

Exploiting the 'survival of the likeliest' to enable evolution-guided drug design

Chuan Liu, Scott Leighow, Haider Inam, Boyang Zhao, Justin R Pritchard
doi: https://doi.org/10.1101/557645
Chuan Liu
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: chuanliu2005@163.com
Scott Leighow
Pennsylvania State University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: sml94@psu.edu
Haider Inam
Pennsylvania State University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: hzi14@psu.edu
Boyang Zhao
Pennsylvania State University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: quantalarity@gmail.com
Justin R Pritchard
Pennsylvania State University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jrp94@psu.edu
  • Abstract
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Article Information

doi 
https://doi.org/10.1101/557645
History 
  • February 22, 2019.

Article Versions

  • You are currently viewing Version 1 of this article (February 22, 2019 - 16:06).
  • View Version 2, the most recent version of this article.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.

Author Information

  1. Chuan Liu1 (chuanliu2005{at}163.com),
  2. Scott Leighow2 (sml94{at}psu.edu),
  3. Haider Inam2 (hzi14{at}psu.edu),
  4. Boyang Zhao2 (quantalarity{at}gmail.com) and
  5. Justin R Pritchard2,3 (jrp94{at}psu.edu)
  1. 1 Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine;
  2. 2 Pennsylvania State University
  1. ↵* Corresponding author; email: jrp94{at}psu.edu
Back to top
PreviousNext
Posted February 22, 2019.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Exploiting the 'survival of the likeliest' to enable evolution-guided drug design
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
Share
Exploiting the 'survival of the likeliest' to enable evolution-guided drug design
Chuan Liu, Scott Leighow, Haider Inam, Boyang Zhao, Justin R Pritchard
bioRxiv 557645; doi: https://doi.org/10.1101/557645
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Exploiting the 'survival of the likeliest' to enable evolution-guided drug design
Chuan Liu, Scott Leighow, Haider Inam, Boyang Zhao, Justin R Pritchard
bioRxiv 557645; doi: https://doi.org/10.1101/557645

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Evolutionary Biology
Subject Areas
All Articles
  • Animal Behavior and Cognition (1546)
  • Biochemistry (2502)
  • Bioengineering (1759)
  • Bioinformatics (9734)
  • Biophysics (3930)
  • Cancer Biology (2996)
  • Cell Biology (4237)
  • Clinical Trials (135)
  • Developmental Biology (2655)
  • Ecology (4133)
  • Epidemiology (2033)
  • Evolutionary Biology (6936)
  • Genetics (5247)
  • Genomics (6534)
  • Immunology (2209)
  • Microbiology (7019)
  • Molecular Biology (2786)
  • Neuroscience (17431)
  • Paleontology (127)
  • Pathology (433)
  • Pharmacology and Toxicology (712)
  • Physiology (1069)
  • Plant Biology (2516)
  • Scientific Communication and Education (647)
  • Synthetic Biology (836)
  • Systems Biology (2700)
  • Zoology (439)